
Without Fundamental Science, How Will the Next Generation of Novel Therapies Emerge?
GUEST COMMENTARY—During a recent venture capital class, I was asked: what percentage of a biotech startup’s equity should a university retain when it is the company’s founders who conceive the key ideas? It is impossible to quantify the impact of the “ …